Evidence map›Paper›PMID 21474431›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2011

Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Susan D Kraner, Qingbo Wang, Kevin R Novak, Dongmei Cheng, David R Cool, Junmin Peng, Mark M Rich

Abstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. A Temporal Examination of Cytoplasmic CaFrontiers in physiology · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Susan D KranerDepartment of Neuroscience, Cell Biology and Physiology, Wright State University, Dayton, Ohio, USA.
Qingbo Wang
Kevin R Novak
Dongmei Cheng
David R Cool
Junmin Peng
Mark M Rich
Wright State University · USEmory University · US

Funding

Loss of muscle excitability in acute quadriplegic myopathyR01NS040826 · NINDS · WRIGHT STATE UNIVERSITY · PI RICH, MARK M · 2001 to 2009
$2.4M
NINDS NIH HHS NS-040826
6 · The paper itself

Abstract

The processes that trigger severe muscle atrophy and loss of myosin in critical illness myopathy (CIM) are poorly understood. It has been reported that muscle disuse alters Ca(2+) handling by the sarcoplasmic reticulum. Since inactivity is an important contributor to CIM, this finding raises the possibility that elevated levels of the proteins involved in Ca(2+) handling might contribute to development of CIM. CIM was induced in 3- to 5-mo-old rats by sciatic nerve lesion and infusion of dexamethasone for 1 wk. Western blot analysis revealed increased levels of ryanodine receptor (RYR) isoforms-1 and -2 as well as the dihydropyridine receptor/voltage-gated calcium channel type 1.1 (DHPR/Ca(V) 1.1). Immunostaining revealed a subset of fibers with elevation of RYR1 and Ca(V) 1.1 that had severe atrophy and disorganization of sarcomeres. These findings suggest increased Ca(2+) release from the sarcoplasmic reticulum may be an important contributor to development of CIM. To assess the endogenous functional effects of increased intracellular Ca(2+) in CIM, proteolysis of α-fodrin, a well-known target substrate of Ca(2+)-activated proteases, was measured and found to be 50% greater in CIM. There was also selective degradation of myosin heavy chain relative to actin in CIM muscle. Taken together, our findings suggest that increased Ca(2+) release from the sarcoplasmic reticulum may contribute to pathology in CIM.

Indexed as

Critical IllnessAnimalsCalciumCaveolin 1DenervationDexamethasoneDisease Models, AnimalFemaleLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMuscular AtrophyMuscular DiseasesMyosinsRatsRats, WistarRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumCalciumCav1 protein, ratCaveolin 1DexamethasoneKcnma1 protein, ratLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMyosinsRyanodine Receptor Calcium Release Channel

Identifiers

PMID21474431
PMCPMC3119150
OpenAlexW2126325231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.